ADC Therapeutics SA (ADCT)
4.06
-0.03
(-0.73%)
USD |
NYSE |
May 20, 10:52
ADC Therapeutics 1 Year Total Returns (Daily): 54.72% for May 17, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 17, 2024 | 54.72% |
| May 16, 2024 | 67.62% |
| May 15, 2024 | 55.85% |
| May 14, 2024 | 72.65% |
| May 13, 2024 | 79.06% |
| May 10, 2024 | 79.17% |
| May 09, 2024 | 110.6% |
| May 08, 2024 | 108.0% |
| May 07, 2024 | 146.4% |
| May 06, 2024 | 127.0% |
| May 03, 2024 | 156.5% |
| May 02, 2024 | 148.9% |
| May 01, 2024 | 140.3% |
| April 30, 2024 | 127.3% |
| April 29, 2024 | 132.0% |
| April 26, 2024 | 121.4% |
| April 25, 2024 | 126.5% |
| April 24, 2024 | 143.9% |
| April 23, 2024 | 116.1% |
| April 22, 2024 | 103.5% |
| April 19, 2024 | 102.6% |
| April 18, 2024 | 106.1% |
| April 17, 2024 | 106.7% |
| April 16, 2024 | 103.7% |
| April 15, 2024 | 100.5% |
| Date | Value |
|---|---|
| April 12, 2024 | 117.3% |
| April 11, 2024 | 128.3% |
| April 10, 2024 | 134.3% |
| April 09, 2024 | 134.3% |
| April 08, 2024 | 149.5% |
| April 05, 2024 | 143.9% |
| April 04, 2024 | 128.6% |
| April 03, 2024 | 116.1% |
| April 02, 2024 | 121.0% |
| April 01, 2024 | 127.7% |
| March 28, 2024 | 131.4% |
| March 27, 2024 | 112.1% |
| March 26, 2024 | 126.6% |
| March 25, 2024 | 118.8% |
| March 22, 2024 | 128.1% |
| March 21, 2024 | 122.7% |
| March 20, 2024 | 125.2% |
| March 19, 2024 | 108.5% |
| March 18, 2024 | 96.88% |
| March 15, 2024 | 56.20% |
| March 14, 2024 | 52.03% |
| March 13, 2024 | 53.54% |
| March 12, 2024 | 62.41% |
| March 11, 2024 | 62.41% |
| March 08, 2024 | 66.05% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-88.33%
Minimum
Nov 09 2023
156.5%
Maximum
May 03 2024
-47.78%
Average
-63.89%
Median
Jun 05 2023
1 Year Total Returns (Daily) Benchmarks
| Roche Holding AG | -14.22% |
| Novartis AG | 5.16% |
| AC Immune SA | 52.15% |
| CRISPR Therapeutics AG | -12.72% |
| Addex Therapeutics Ltd | -44.37% |